ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

8,838Medicare Part D Prescriptions Filled, Including Refills
$559K Total Retail Price of All Prescriptions
292 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 486 219 S3
OMEPRAZOLE 295 166
AMLODIPINE BESYLATE 281 178
METFORMIN HCL 262 135
LEVOTHYROXINE SODIUM 242 192
LISINOPRIL 240 167
CARVEDILOL 210 158
ZOLPIDEM TARTRATE 207 122
LOSARTAN POTASSIUM 194 131
HYDROCHLOROTHIAZIDE 189 118
ENALAPRIL MALEATE 177 75
SIMVASTATIN 173 92
FUROSEMIDE 156 77
PROAIR HFA 136 60
METOPROLOL TARTRATE 126 91
CRESTOR 123 72
GABAPENTIN 122 57
RANITIDINE HCL 117 75
LOVASTATIN 113 49
ATENOLOL 104 84
TRAZODONE HCL 99 50
BACLOFEN 95 20
ACETAMINOPHEN-CODEINE 94 68 S3
ROPINIROLE HCL 90 25
FENOFIBRATE 89 31
GLIPIZIDE 87 58
ATORVASTATIN CALCIUM 82 71
PRAVASTATIN SODIUM 81 49
MORPHINE SULFATE ER 77 0 S2
POTASSIUM CHLORIDE 77 39
LANTUS SOLOSTAR 74 32
NEXIUM 73 46
CITALOPRAM HBR 73 46
AZITHROMYCIN 73 32
PEN NEEDLE 65 27
METHOCARBAMOL 63 15 R
MICARDIS 61 46
ESCITALOPRAM OXALATE 58 45
FLUTICASONE PROPIONATE 57 20
CYCLOBENZAPRINE HCL 55 16 R
LOVAZA 52 25
PROMETHAZINE HCL 52 0 R
PHENYTOIN SODIUM EXTENDED 50 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.